
Sign up to save your podcasts
Or


By Infinity Peptides
We will discuss the preclinical trial information on Bpc157 what have we heard what have we experienced, along with where does it come from.
‘RSSVERIFY’
... more2.5
1717 ratings
The podcast currently has 85 episodes available.
The most played episodes among Podcast App listeners.

Pinealon is a three-amino acid synthetic peptide developed in Russia as part of the Khavinson bioregulator family to support the central nervous system. Proponents suggest it may improve cognitive function, regulate circadian rhythms, and offer neuroprotection by influencing gene expression and reducing oxidative stress. While animal and laboratory studies show promise for treating brain aging and oxidative injury, there is a significant lack of large-scale human clinical trials to verify these claims. The biohacking community frequently uses the substance for sleep enhancement and mental clarity, yet anecdotal reports remain inconsistent and scientifically unproven. Ultimately, while the peptide is a popular subject for longevity research, its clinical efficacy and long-term safety profile have not been established by independent international standards.

These sources provide a comprehensive overview of Retatrutide, an experimental "triple agonist" peptide that targets three metabolic switches to produce unprecedented weight loss and organ protection. Beyond simply reducing body mass, the data suggests the drug can nearly eliminate fatty liver disease, significantly decrease chronic joint pain, and improve markers for heart and kidney health. Medical experts emphasize that success with this therapy requires rigorous lifestyle foundations, including high protein intake and resistance training to prevent the loss of lean muscle mass. Monitoring vital signs and blood markers is also essential, as the drug’s activation of the glucagon receptor can increase heart rate and impact metabolic balance. Ultimately, the sources frame this medication as a potential reset for the metabolic system rather than a traditional diet drug, marking a new era in treating obesity-related chronic illnesses.

Dulaglutide, marketed as Trulicity, is a once-weekly injectable medication that revolutionized the management of type 2 diabetes by mimicking the natural GLP-1 hormone. The provided text highlights its role as a precursor to more famous drugs like Ozempic, offering patients reliable blood sugar regulation, cardiovascular protection, and kidney health benefits. While newer medications provide more dramatic weight loss results, this drug is praised for its extensive clinical data and a well-documented safety profile established through major trials like AWARD and REWIND. Beyond its primary medical use, the biohacking community views it as a dependable tool for appetite suppression and metabolic stability. Ultimately, the sources position dulaglutide as a foundational therapy that remains relevant due to its long-term proven efficacy.

This is a blend of bpc157, Tb500 and Ghkcu the copper peptide

Semaglutide vs Tirzepatide and now Retatrutide the possible new standard
FDA and Peptides
Retatrutide
The podcast currently has 85 episodes available.

7,181 Listeners

4,998 Listeners

12,109 Listeners

335 Listeners

67 Listeners

122 Listeners

299 Listeners

1,681 Listeners

369 Listeners

102 Listeners

42 Listeners

38 Listeners

40 Listeners

76 Listeners

79 Listeners